Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$11,072,330
+$328,459 QoQ
Shares Held
43,597
-0.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.19%
of 13F equity value
Holder Rank
#1,051
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SMITHBRIDGE ASSET MANAGEMENT INC/DE holds $39,618,201 across 7 Drug Manufacturers - General names. JNJ ranks #1 (27.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
43,597 | $11,072,330 | |
| 2 | NVS |
Novartis AG
|
49,133 | $7,700,123 | |
| 3 | ABBV |
AbbVie Inc.
|
29,215 | $7,351,662 | |
| 4 | LLY |
ELI LILLY & Co
|
5,883 | $7,056,247 | |
| 5 | NVO |
Novo Nordisk A S
|
102,069 | $4,893,187 | |
| 6 | MRK |
Merck & Co., Inc.
|
10,048 | $1,291,168 | |
| 7 | AMGN |
Amgen Inc
|
700 | $253,484 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,072,330 | 43,597 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $10,743,871 | 43,953 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $17,628,621 | 85,183 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $7,708,280 | 41,572 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $6,410,459 | 41,967 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $6,846,041 | 41,281 | Shares | Sole | 2025-04-16 | |
| 2024-09-30 | $6,598,272 | 40,715 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $5,873,878 | 40,188 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $7,173,758 | 45,349 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $7,107,375 | 45,345 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $7,096,281 | 45,562 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $7,421,254 | 44,836 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $6,962,600 | 44,920 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $7,558,500 | 42,788 | Shares | Sole | 2023-03-01 | |
| 2022-09-30 | $6,952,764 | 42,561 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $7,380,688 | 41,579 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $7,349,196 | 41,467 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $6,873,421 | 40,179 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $6,421,886 | 39,764 | Shares | Sole | 2021-10-04 | |
| 2021-06-30 | $6,722,709 | 40,808 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $6,599,145 | 40,153 | Shares | Sole | 2021-04-06 | |
| 2020-12-31 | $6,046,224 | 38,418 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $5,752,723 | 38,640 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $5,385,285 | 38,294 | Shares | Sole | 2020-07-01 | |
| 2020-03-31 | $5,023,459 | 38,309 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||